Menu

All Activities

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information

Featured Activity

This activity will cover key topics of interest to stakeholders who set practice policy and will be called upon to evaluate and make decisions on issues pertaining to biosimilars.

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

SHOW SEARCH

Planning for a Seamless Transition for Infusion Pump Integration with the EHR

Activity Downloads

To Participate

To participate in this continuing education activity:

  1. Review the activity description and objectives.
  2. View the activity.
  3. Complete the online post-test and activity evaluation.

NOTE: If you attended the live CE activity titled "Planning for a Seamless Transition for Infusion Pump Integration with the EHR" that was held on December 4, 2016 during the 51st ASHP Midyear Clinical Meeting & Exhibition in Las Vegas, Nevada AND received CE credit (i.e. a pharmacist or pharmacy technician CE statement with ACPE Universal Activity Number 0221-9999-16-318-L05-P/T), you are ineligible to also receive CE credit for this home-study activity.

Activity Description

Integration of "smart" infusion pumps with other technology such as computerized physician order entry (CPOE) and electronic health records (EHRs) is a huge step forward in reducing pump programming errors and enhancing safe administration of IV medications. This activity will provide you with key information on how to prepare your organization for auto-programming of IV infusions and optimization of closed-loop technologies. An overview of the planning and implementation process in two different EHR systems will be provided, paying particular attention to the human factors, technology readiness, environment, and system challenges faced during the process. Current issues affecting the use of integrated smart pump technology will also be explored as well as the importance of using device-generated data to evaluate practice patterns, alarm fatigue, and organizational culture of safety.

Learning Objectives

The target audience for this activity includes pharmacists, pharmacy technicians, and nurses. Upon completion of this activity, participants will be able to:

  • Summarize the scope of IV infusion errors that continue to occur despite the use of smart infusion pumps.
  • Describe the components and advantages of integrated infusion management for the benefit of patient safety and workflow efficiency.
  • Outline the elements necessary for successful standardization of drug nomenclature and formulary adjustments in advance of pump integration.
  • Discuss challenges that hospitals may face after smart infusion pump integration with the EHR.
  • Examine some of the strategies used during successful auto-programming of IV infusion devices.

Faculty

Moderator: Michael R. Cohen, RPh, MS, ScD (hon.), DPS (hon.), FASHP
President
Institute for Safe Medication Practices
Horsham, Pennsylvania

Joanna Caranante, PharmD, BCPS
Pharmacy Clinical Director and Residency Program Director
St. Joseph’s Hospital
Tampa, Florida

Michelle Mandrack, MSN, RN
Director of Consulting Services
Institute for Safe Medication Practices
Horsham, Pennsylvania

Sondra May, PharmD
Medication Safety Coordinator
University of Colorado Hospital
Aurora, Colorado

Disclosure

It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. Dr. Caranante received financial support from Carefusion for participation in a panel discussion. Conflicts identified were resolved with a peer review process. Dr. Cohen, Ms. Mandrack, and Dr. May have no relevant commercial or financial relationships to disclose.

Please note: The opinions expressed in this activity should not be construed as those of the CME/CE provider. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include unlabeled indications. Use of drugs and devices outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.

CE Accreditation

Release Date: 02-21-2017
Expiration Date: 02-21-2019

Pharmacists and Pharmacy Technicians

This CE activity is jointly provided by ProCE, Inc. and the Institute for Safe Medication Practices (ISMP). ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-17-086-H05-P/T has been assigned to this knowledge-based home-study CE activity (initial release date 2-21-17). This activity is approved for 1.5 contact hours (0.15 CEU) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Statements of completion will be issued online at www.ProCE.com upon completion of the evaluation and post-test with a score of 70% or higher. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.

Nurses

This CE activity is jointly provided by ProCE, Inc. and Wild Iris Medical Education, Inc. This activity provides 1.5 contact hours of nurse CE credit.

Wild Iris Medical Education, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Funding

This CE activity is supported by an educational grant from BD.

 

The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.